000 01122 a2200289 4500
005 20250513115926.0
264 0 _c19970602
008 199706s 0 0 eng d
022 _a0891-1150
024 7 _a10.3949/ccjm.64.5.234
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHobbs, R E
245 0 0 _aDigoxin's effect on mortality and hospitalization in heart failure: implications of the DIG study. Digitalis Investigation Group.
_h[electronic resource]
260 _bCleveland Clinic journal of medicine
_cMay 1997
300 _a234-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
650 0 4 _aCanada
650 0 4 _aCardiotonic Agents
_xtherapeutic use
650 0 4 _aDigoxin
_xtherapeutic use
650 0 4 _aDouble-Blind Method
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHospitalization
650 0 4 _aHumans
650 0 4 _aUnited States
773 0 _tCleveland Clinic journal of medicine
_gvol. 64
_gno. 5
_gp. 234-7
856 4 0 _uhttps://doi.org/10.3949/ccjm.64.5.234
_zAvailable from publisher's website
999 _c9130777
_d9130777